Benlysta 120 mg and 400 mg powder for concentrate for solution for infusion *

• Company:

  GlaxoSmithKline (Ireland) Ltd

• Status:

  Updated

• Legal Category:

  Product subject to medical prescription which may not be renewed (A)

• Active Ingredient(s):

  Belimumab

  This medicinal product is subject to additional monitoring.

  *Additional information is available within the SPC or upon request to the company